Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions

Abstract

Our study systematically identified novel melanoma-specific genes and showed the feasibility of using a combination of PLAB and L1CAM in a reverse transcription-PCR assay to differentiate clinically relevant samples containing benign or malignant melanocytes.